Back to Newsroom
Back to Newsroom

Predictmedix Secures Inaugural Placement of Safe Entry Station at Health and Wellness Retreat in Ontario, Canada

Thursday, 16 December 2021 08:31 AM

Predictmedix

Ste. Anne's Spa, an Ontario-Based Health and Wellness Retreat, to Rollout Safe Entry Station Solution to Ensure Safe Environment for Staff & Guests

Health Retreat & Resort Market Represents Significant New Addressable Opportunity

TORONTO, ON / ACCESSWIRE / December 16, 2021 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the inaugural health and wellness placement of the Company's proprietary Safe Entry Station technology at Ste. Anne's Spa, a popular health and wellness retreat in Ontario.

This new placement was secured through the Company's North American partner, Juiceworks Exhibits, and SBL Testing Technologies. By implementing this leading-edge technology, St. Anne's Spa has demonstrated its commitment to creating a safe space for its guests and staff.

This marks the Company's foray into the hospitality space, as the public demand for safe vacations and relaxation experiences is hitting an all-time high.

"We are pleased to announce this new placement at Ste. Anne's Spa in Ontario, an exciting entry into the global resort market, helping the industry return to its pre-COVID status through stringent detection of infectious diseases - providing a safe and secure environment for guests and employees," said Dr. Rahul Kushwah, Interim Chief Executive Officer of Predictmedix. "We believe that this placement represents the first of many future placements at resorts globally - particularly given the resurgence in COVID-19 with the Omicron variant - indicating that dangerous infectious diseases will likely be a part of our everyday lives for years to come."

"The Omicron variant only further validates the importance of identifying disease symptoms before the illness can be further transmitted - allowing innovative companies like Predictmedix the opportunity to create incredible long-term value for both our customers and shareholders," concluded Kushwah.

"SBL's global clientele and partner base is growing rapidly as organizations realize the COVID-19 pandemic is shifting to an endemic, requiring long-term solutions to mitigate and manage infectious disease risk. Safe Entry & SBL's risk solutions deliver a long-term Pandemic Response / Business Continuity solution," stated Rich Robillard, Managing Director at SBL Testing Technologies Inc.

"More than anything, guests arriving at our spa are seeking peace of mind as they seek to disconnect from the stresses of the modern world. The Safe Entry System adds one more layer to our already robust protocols designed to help everyone feel safe as they start their journey to rest, relaxation and rejuvenation." said Jim Corcoran, Owner and GM at Ste. Anne's Spa.

About Predictmedix Inc.

Predictmedix (CSE: PMED) (OTCQB: PMEDF) is a leading provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, or various mental illnesses. Predictmedix's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.

About Ste. Anne's Spa

Enjoy a peaceful country spa retreat nestled within 400 acres of rolling country hills in Ontario's Northumberland County only 90 minutes east of downtown Toronto. Perched on the hill with views of Lake Ontario, Ste. Anne's Spa offers a rejuvenating blend of tranquility, delectable and healthy cuisine, wellness classes and spa treatments while staying in luxurious accommodation featuring beautifully appointed rooms in the Main Inn or individually crafted cottages.

Ste. Anne's has garnered numerous Canadian and international spa awards and is a leader in providing innovative and therapeutic treatments. Engage in activities from meditation, yoga, and breathing classes to horse whisperer-like experiences at its equestrian centre. Sit back and relax outside admiring the enchanting gardens, soak in the hydrotherapy pools or venture inside the inn with its state-of-the-art massage chairs or be pampered at the spa with a full range of esthetic and body treatments. Foodies won't be disappointed with a full slate of healthy and tasty menu options where you can dine inside or outside. Ste. Anne's is an all-inclusive, four-season, spa resort that will satisfy all the senses.

To learn more, please visit our website at https://www.steannes.com/ or follow us on https://www.instagram.com/steannesspa/ or https://twitter.com/steannesspa

Investor Relations Contact
Lucas A. Zimmerman
MZ Group - MZ North America
949-259-4987
[email protected]
www.mzgroup.us

Caution Regarding Forward-Looking Information:

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.

All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.

Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time."

SOURCE: Predictmedix

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: